Class II ยท Moderate risk
MVASI (bevacizumab-awwb)
Defective container: loose crimp defect, potential loss of container integrity.
National Drug Code
Is NDC 55513-0206-01 recalled?
Mvasi · 1 VIAL in 1 CARTON (55513-206-01) / 4 mL in 1 VIAL
Yes — this exact package was recalled
1 FDA recall names the code 55513-0206-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- bevacizumab-awwb
- Strength
- BEVACIZUMAB 100 mg/4mL
- Form
- Injection, Solution · Intravenous
- Labeler
- Amgen, Inc
- Type
- Human Prescription Drug
- Product code
- 55513-0206
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 55513-0710 Prolia 3
- 55513-0073 Sensipar 2
- 55513-0074 Sensipar 2
- 55513-0075 Sensipar 1
- 55513-0530 Neupogen 1
- 55513-0546 Neupogen 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.